MA44859A - Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes - Google Patents
Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantesInfo
- Publication number
- MA44859A MA44859A MA044859A MA44859A MA44859A MA 44859 A MA44859 A MA 44859A MA 044859 A MA044859 A MA 044859A MA 44859 A MA44859 A MA 44859A MA 44859 A MA44859 A MA 44859A
- Authority
- MA
- Morocco
- Prior art keywords
- pseudodimers
- oxazoline
- pharmaceutical compositions
- related use
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662331710P | 2016-05-04 | 2016-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA44859A true MA44859A (fr) | 2019-03-13 |
Family
ID=58709615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA044859A MA44859A (fr) | 2016-05-04 | 2017-05-04 | Pseudodimères d'oxazoline, compositions pharmaceutiques et utilisation correspondantes |
Country Status (6)
Country | Link |
---|---|
US (1) | US10858326B2 (fr) |
EP (1) | EP3452473A1 (fr) |
JP (1) | JP2019514960A (fr) |
CN (1) | CN109071518A (fr) |
MA (1) | MA44859A (fr) |
WO (1) | WO2017192858A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019514960A (ja) | 2016-05-04 | 2019-06-06 | パーデュー ファーマ エルピー | オキサゾリンシュードダイマー、医薬組成物及びその使用 |
EP3463359A4 (fr) * | 2016-06-02 | 2020-08-26 | Purdue Pharma LP | Agonistes du récepteur 1 associé à une amine à l'état de trace et agonistes partiels pour le traitement de la douleur |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
CA2675221C (fr) | 2007-02-02 | 2016-02-23 | F. Hoffmann-La Roche Ag | Nouvelles 2-aminooxazolines servant de ligands du taar1 pour des troubles du snc |
KR101222412B1 (ko) | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Taar1 리간드로서의 2-아미노옥사졸린 |
RU2513086C2 (ru) * | 2008-07-24 | 2014-04-20 | Ф.Хоффманн-Ля Рош Аг | Производные 4,5-дигидро-оксазол-2-ила |
US20100311798A1 (en) | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
US9132136B2 (en) * | 2010-08-02 | 2015-09-15 | Hoffmann-La Roche Inc. | Pharmaceutical combination |
US8673950B2 (en) * | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
US8802673B2 (en) * | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
ES2554843T3 (es) * | 2012-01-12 | 2015-12-23 | F. Hoffmann-La Roche Ag | Derivados heterocíclicos como receptores asociados de trazas de amina (TAARs) |
JP2019514960A (ja) | 2016-05-04 | 2019-06-06 | パーデュー ファーマ エルピー | オキサゾリンシュードダイマー、医薬組成物及びその使用 |
-
2017
- 2017-05-04 JP JP2018557896A patent/JP2019514960A/ja active Pending
- 2017-05-04 WO PCT/US2017/031071 patent/WO2017192858A1/fr unknown
- 2017-05-04 EP EP17723874.8A patent/EP3452473A1/fr not_active Withdrawn
- 2017-05-04 US US16/098,494 patent/US10858326B2/en active Active
- 2017-05-04 MA MA044859A patent/MA44859A/fr unknown
- 2017-05-04 CN CN201780027262.9A patent/CN109071518A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2017192858A1 (fr) | 2017-11-09 |
CN109071518A (zh) | 2018-12-21 |
EP3452473A1 (fr) | 2019-03-13 |
JP2019514960A (ja) | 2019-06-06 |
US10858326B2 (en) | 2020-12-08 |
US20190144400A1 (en) | 2019-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44740A (fr) | Variantes de capsides de virus adéno-associé et leurs procédés d'utilisation | |
MA45280A (fr) | Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation | |
MA52257A (fr) | Compositions pharmaceutiques comprenant blautia et leur administration orale | |
MA55571A (fr) | Compositions pharmaceutiques comprenant n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
MA50541A (fr) | Formulations pharmaceutiques | |
DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
MA52098A (fr) | Agonistes de ppar, composés, compositions pharmaceutiques et leurs procédés d'utilisation | |
MA46867A (fr) | Formulations pharmaceutiques | |
MA42303A (fr) | Formulations pharmaceutiques | |
DK3634377T3 (da) | Farmaceutisk formulering | |
MA40759A (fr) | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation | |
DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
MA50403A (fr) | Promédicaments de dantrolène et leurs procédés d'utilisation | |
MA45187A (fr) | Combinaisons pharmaceutiques | |
IL273339A (en) | Griseofulbin compound and its medical use | |
MA49837A (fr) | Compositions pharmaceutiques | |
IL248785B (en) | Antecedents of ]-n5,1-dimethyl3--oxo-(3,2-dihydro-h1-pyrazol-4-yl)]-methyl-isoxazole-3-carboxamide and pharmaceutical preparations including these antecedents | |
BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
MA55015A (fr) | Formulations pharmaceutiques | |
FR3020946B1 (fr) | Nouvelles preparations cosmetiques et/ou dermatologiques extemporanees | |
MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
DK4023651T3 (da) | Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme | |
BR112018005299A2 (pt) | 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso |